APL-5125

N/A

Report date: 2024/11/27 16:46:45

Base Information

Drug NameAPL-5125
Drug Alias NameAPL-5125
ClassificationBiologics
Mechanisms of ActionWingless type MMTV integration site family protein inhibitors
TargetsWingless type MMTV integration site family protein
Therapy Area/IndicationsProstatic NeoplasmsEndometrial NeoplasmsOvarian Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesApollo Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesApollo Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsEndometrial NeoplasmsOvarian Neoplasms +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A